These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2963518)

  • 1. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty.
    Galan KM; Deligonul U; Kern MJ; Chaitman BR; Vandormael MG
    Am J Cardiol; 1988 Feb; 61(4):260-3. PubMed ID: 2963518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.
    Bresee SJ; Jacobs AK; Garber GR; Ruocco NA; Mills RM; Bergelson BA; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Nov; 68(11):1158-62. PubMed ID: 1951074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic patterns of restenosis after angioplasty of multiple coronary arteries.
    DiSciascio G; Cowley MJ; Vetrovec GW
    Am J Cardiol; 1986 Nov; 58(10):922-5. PubMed ID: 2946214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.
    Ellis SG; Shaw RE; Gershony G; Thomas R; Roubin GS; Douglas JS; Topol EJ; Startzer SH; Myler RK; King SB
    Am J Cardiol; 1989 Apr; 63(13):897-901. PubMed ID: 2522727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.
    Ellis SG; Roubin GS; King SB; Douglas JS; Cox WR
    Am J Cardiol; 1989 Jan; 63(1):30-4. PubMed ID: 2521196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience.
    Guiteras Val P; Bourassa MG; David PR; Bonan R; Crépeau J; Dyrda I; Lespérance J
    Am J Cardiol; 1987 Jul; 60(3):50B-55B. PubMed ID: 2956844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty.
    Glazier JJ; Varricchione TR; Ryan TJ; Ruocco NA; Jacobs AK; Faxon DP
    Am J Cardiol; 1989 Apr; 63(13):902-5. PubMed ID: 2522728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.
    Holmes DR; Vlietstra RE; Smith HC; Vetrovec GW; Kent KM; Cowley MJ; Faxon DP; Gruentzig AR; Kelsey SF; Detre KM
    Am J Cardiol; 1984 Jun; 53(12):77C-81C. PubMed ID: 6233894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of coronary artery disease after percutaneous transluminal coronary angioplasty.
    Hwang MH; Sihdu P; Pacold I; Johnson S; Scanlon PJ; Loeb HS
    Am Heart J; 1988 Feb; 115(2):297-301. PubMed ID: 2963511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-HEART Group.
    Macdonald RG; Henderson MA; Hirshfeld JW; Goldberg SH; Bass T; Vetrovec G; Cowley M; Taussig A; Whitworth H; Margolis JR
    Am J Cardiol; 1990 Oct; 66(12):926-31. PubMed ID: 2220614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
    Serruys PW; Luijten HE; Beatt KJ; Geuskens R; de Feyter PJ; van den Brand M; Reiber JH; ten Katen HJ; van Es GA; Hugenholtz PG
    Circulation; 1988 Feb; 77(2):361-71. PubMed ID: 2962786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preangioplasty complicated coronary stenosis morphology as a predictor of restenosis.
    Tousoulis D; Kaski JC; Davies G; Pereira W; el Tamimi H; McFadden E; Maseri A
    Am Heart J; 1992 Jan; 123(1):15-20. PubMed ID: 1729818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic morphology of restenosis after percutaneous transluminal coronary angioplasty.
    MacDonald RG; Barbieri E; Feldman RL; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(1):50-4. PubMed ID: 2955692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.
    Schmitz HJ; Erbel R; Meyer J; von Essen R
    Am Heart J; 1996 May; 131(5):884-91. PubMed ID: 8615306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis and its determinants in first and repeat coronary angioplasty.
    Rapold HJ; David PR; Guiteras Val P; Mata AL; Crean PA; Bourassa MG
    Eur Heart J; 1987 Jun; 8(6):575-86. PubMed ID: 2957201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.